Decoding post-myocardial infarction coronary microvascular dysfunction: The SP1-driven STAT3/KCa3.1/eNOS protective...

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Cellular Physiology

Background:

• Coronary microvascular dysfunction post-myocardial infarction (MI) impairs cardiac repair.
• Hyperhomocysteinemia (HHcy) exacerbates microvascular damage after MI.
• The role of transcription factor SP1 in HHcy-induced microvascular dysfunction post-MI is not fully understood.

Purpose of the Study:

• To investigate the mechanism of SP1 in reversing HHcy-induced microvascular dysfunction after MI.
• To elucidate the signaling pathway involved in SP1-mediated protection.

Main Methods:

• Utilized HHcy mouse and human coronary artery endothelial cell (HCAEC) models.
• Assessed cardiac microvascular perfusion and protein expression via Western blot.
• Employed specific inhibitors (L-NAME, Stattic) to validate the STAT3/KCa3.1/eNOS pathway.

Main Results:

• SP1 significantly improved microvascular function and angiogenesis in HHcy mice post-MI.
• SP1 activated the STAT3/KCa3.1/eNOS signaling pathway, crucial for endothelial nitric oxide synthase (eNOS) activity.
• SP1 protected HCAECs from homocysteine and hypoxia-induced damage via this pathway.

Conclusions:

• SP1 reverses HHcy-induced microvascular dysfunction post-MI by activating the STAT3/KCa3.1/eNOS pathway.
• This study provides novel insights into the molecular mechanisms of post-MI cardiovascular complications.
• SP1 represents a potential therapeutic target for cardiovascular disease treatment.